Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Stickstoff(II)-oxid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Beyond Air Announces $5M Private Placement Under Nasdaq Rules
    Beyond Air Announces $5M Private Placement Under Nasdaq Rules

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218639/0/en/Beyond-Air-Announces-5-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    Beyond Air Signs Lungfit PH Distribution Deals In Germany
    Beyond Air Signs Lungfit PH Distribution Deals In Germany

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206903/0/en/Beyond-Air-Signs-New-International-LungFit-PH-Distribution-Agreements-Most-Notably-in-Germany-and-Brazil.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Biossil Acquire Galera Therapeutics' Dismutase Mimetics portfolio
    Biossil Acquire Galera Therapeutics' Dismutase Mimetics portfolio

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170932/0/en/Galera-Therapeutics-Announces-Acquisition-of-Dismutase-Mimetics-Portfolio-by-Toronto-based-Biossil-for-up-to-105-Million.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    Beyond Air Exercises Warrants for $3.25M Gross Proceeds
    Beyond Air Exercises Warrants for $3.25M Gross Proceeds

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3146420/0/en/Beyond-Air-Announces-Exercise-of-Warrants-for-3-25-Million-of-Gross-Proceeds.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    Beyond Air Sets Q1 2026 Financial Results Call and Webcast
    Beyond Air Sets Q1 2026 Financial Results Call and Webcast

    25 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/25/3121752/0/en/Beyond-Air-Schedules-First-Fiscal-Quarter-2026-Financial-Results-Conference-Call-and-Webcast.html

    GLOBENEWSWIRE
    25 Jul 2025
    Share Share
    Beyond Air Granted U.S. Patent for NTM Infection Treatment
    Beyond Air Granted U.S. Patent for NTM Infection Treatment

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067906/0/en/Beyond-Air-Granted-U-S-Patent-Covering-Treatment-of-NTM-Infections-Using-gaseous-Nitric-Oxide-gNO.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.